Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Jones

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Antioxidants & Redox Signaling|October 23, 2014
Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and diseaseCharis L Himeda, Takako I Jones, Peter L Jones
Trends in Pharmacological Sciences|February 27, 2016
Scalpel or Straitjacket: CRISPR/Cas9 Approaches for Muscular DystrophiesCharis L Himeda, Takako I Jones, Peter L Jones
Molecular Therapy. Methods & Clinical Development|September 2, 2025
All-in-one vectors for epigenetic CRISPR inhibition of <i>DUX4-fl</i> in facioscapulohumeral muscular dystrophyCharis L Himeda, Takako I Jones, Peter L Jones
Methods in Molecular Biology (Clifton, N.J.)|April 16, 2002
Purification of MeCP2-containing deacetylase from Xenopus laevisPeter L Jones, Paul A Wade, Alan P Wolffe
Developmental Dynamics : an Official Publication of the American Association of Anatomists|December 20, 2008
Muscular dystrophy candidate gene FRG1 is critical for muscle developmentMeredith L Hanel, Ryan D Wuebbles, Peter L Jones
Human Gene Therapy|July 6, 2024
Have a Little Heart (or Not): Highly Minimized Skeletal Muscle Regulatory Cassettes with Low or No Activity in the HeartCharis L Himeda, Takako I Jones, Peter L Jones
Molecular Therapy. Methods & Clinical Development|January 29, 2021
Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic <i>DUX4-fl</i> expression in FSHDCharis L Himeda, Takako I Jones, Peter L Jones
Trends in Molecular Medicine|March 25, 2015
Emerging preclinical animal models for FSHDAngela Lek, Fedik Rahimov, Peter L Jones, et al.
Disease Models & Mechanisms|August 2, 2021
Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse modelsAndreia M Nunes, Monique Ramirez, Takako I Jones, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Transgenic mouse models for investigating human <i>DUX4</i> expression during development and its roles in FSHD pathophysiologyYosuke Hiramuki, Charis L Himeda, Peter L Jones, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Antioxidants & Redox Signaling|October 23, 2014
Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and diseaseCharis L Himeda, Takako I Jones, Peter L Jones
Trends in Pharmacological Sciences|February 27, 2016
Scalpel or Straitjacket: CRISPR/Cas9 Approaches for Muscular DystrophiesCharis L Himeda, Takako I Jones, Peter L Jones
Molecular Therapy. Methods & Clinical Development|September 2, 2025
All-in-one vectors for epigenetic CRISPR inhibition of <i>DUX4-fl</i> in facioscapulohumeral muscular dystrophyCharis L Himeda, Takako I Jones, Peter L Jones
Methods in Molecular Biology (Clifton, N.J.)|April 16, 2002
Purification of MeCP2-containing deacetylase from Xenopus laevisPeter L Jones, Paul A Wade, Alan P Wolffe
Developmental Dynamics : an Official Publication of the American Association of Anatomists|December 20, 2008
Muscular dystrophy candidate gene FRG1 is critical for muscle developmentMeredith L Hanel, Ryan D Wuebbles, Peter L Jones
Human Gene Therapy|July 6, 2024
Have a Little Heart (or Not): Highly Minimized Skeletal Muscle Regulatory Cassettes with Low or No Activity in the HeartCharis L Himeda, Takako I Jones, Peter L Jones
Molecular Therapy. Methods & Clinical Development|January 29, 2021
Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic <i>DUX4-fl</i> expression in FSHDCharis L Himeda, Takako I Jones, Peter L Jones
Trends in Molecular Medicine|March 25, 2015
Emerging preclinical animal models for FSHDAngela Lek, Fedik Rahimov, Peter L Jones, et al.
Disease Models & Mechanisms|August 2, 2021
Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse modelsAndreia M Nunes, Monique Ramirez, Takako I Jones, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Transgenic mouse models for investigating human <i>DUX4</i> expression during development and its roles in FSHD pathophysiologyYosuke Hiramuki, Charis L Himeda, Peter L Jones, et al.
Pageof 8